# Akamis Bio

**Canonical:** https://apis.io/providers/akamis-bio/  
**Website:** https://www.nasdaqprivatemarket.com/  
**APIs profiled:** 0

Akamis Bio is a biotechnology company focused on developing oncolytic immunotherapies for colorectal cancer. Their mission is to transform treatment by creating therapies that stimulate the body’s immune system to recognize, attack, and clear tumors, addressing a critical unmet need in a disease that is the second leading cause of cancer deaths worldwide.

## Kin Score — 2.1 / 100 (minimal)

Scored 2026-09-25 under rubric 0.23.0.

| Facet | Score |
|---|---|
| Discoverability | 35.7 |
| Contract Quality | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Horizontal (data, software, accessibility, platform)**: 5.9 (matched via fallback).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |

## Security (1)

- **Akamis Bio Domain Security** — TLSv1.3 · HSTS · DMARC

## Tags

Company

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/akamis-bio/). Scores are computed from the provider's own public artifacts under a published rubric.